Additionally, the strong nuclear expression of HDAC1, HDAC2, and NCOR2 in glioma cells, along with weak expression of NCOR1 and HDAC3, suggests a potential role for these proteins in tumor progression and as markers for patient prognosis [38]. The gene discussed is HDAC3; the disease is neoplasm.